New targeted therapies have been developed to overcome resistance to endocrine therapy (ET) and improve the outcome of HR+/HER2-advanced breast cancer (ABC).We
The mammalian target of rapamycin (mTOR) critically regulates several essential biological functions,such as cell growth,metabolism,survival,and immune response